Eye-Drop and Lubricants Market Report 2026

The eye-drop and lubricants market size has grown strongly in recent years. It will grow from $21.63 billion in 2025 to $22.79 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increasing prevalence of eye disorders, expansion of self-medication practices, rising awareness of eye hygiene, growth of pharmacy retail networks, improved access to ophthalmic products.

The eye-drop and lubricants market size is expected to see strong growth in the next few years. It will grow to $27.78 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing demand for advanced eye care solutions, expansion of online retail distribution, growing focus on chronic eye condition management, rising adoption among elderly populations, increasing investment in ophthalmic research. Major trends in the forecast period include increasing demand for preservative-free eye lubricants, rising adoption of multi-dose delivery systems, growing use of combination eye care therapies, expansion of gel and ointment formulations, enhanced focus on long-lasting relief.

The rising prevalence of vision-related conditions is expected to drive the growth of the eye-drop and lubricants market in the coming years. Vision-related cases encompass medical conditions, disorders, or issues that impair clear or comfortable vision. This rise is primarily driven by increased screen time, which contributes to digital eye strain and accelerates the development of myopia, particularly among children and young adults. Eye drops and lubricants help alleviate symptoms associated with vision-related conditions, such as dryness, irritation, and redness, by providing hydration, reducing inflammation, and stabilizing the tear film, thereby improving overall eye comfort and visual clarity. For instance, in October 2024, according to the Royal National Institute of Blind People, a UK-based charity supporting individuals with visual impairments, the number of people with severe sight loss or registered as blind is projected to rise by 29%, increasing from 298,000 in 2022 to 379,000 by 2035. Therefore, the rising prevalence of vision-related conditions is fueling the growth of the eye-drop and lubricants market.

Major companies in the eye-drop and lubricants market are focusing on launching innovative solutions, such as vitamin D3-enriched lubricating eye drops, to more effectively address dry eye symptoms and meet the growing demand for multifunctional ocular health products. Vitamin D3-enriched lubricating eye drops are ophthalmic formulations combining vitamin D3 (cholecalciferol) with moisturizing agents to relieve dryness while providing anti-inflammatory and immune-modulating benefits. For instance, in May 2024, Entod Pharmaceuticals, an India-based pharmaceutical company, introduced vitamin D3-enriched lubricating eye drops, representing a significant advancement in ocular care by offering targeted relief for individuals with dry eye syndrome. This formulation incorporates vitamin D3 into select lubricant eye drops to improve ocular surface health, enhance tear stability, and support corneal wound healing. The product is available by prescription only, addressing widespread vitamin D deficiency in India, which is associated with eye health issues such as age-related macular degeneration and diabetic retinopathy.

In April 2023, Nirma Group, an India-based chemical company, acquired Stericon Pharma for an undisclosed amount. Through this acquisition, Nirma aims to strengthen its presence in the pharmaceutical sector, particularly in ophthalmic products and sterile manufacturing, complementing its existing healthcare vertical, Aculife Healthcare, and supporting its broader strategy of expansion and acquisitions in the pharma space. Stericon Pharma is an India-based pharmaceutical company specializing in sterile multipurpose contact lens cleaning solutions, eye drops, and eye lubricants.

Major companies operating in the eye-drop and lubricants market are Bayer AG, Sanofi S.A., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Alcon Inc., Bausch + Lomb Incorporated, Santen Pharmaceutical Co. Ltd., Nicox S.A., Scope Ophthalmics Ltd., Lenz Therapeutics Inc., Eyeris Vision Care Pvt. Ltd., Akums Drugs and Pharmaceuticals Ltd., Medtech Products Inc., Rohto Pharmaceutical Co. Ltd, Eyevance Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd, Johnson & Johnson Vision, Similasan Corporation, Sager Pharma Kft, Cipla Ltd, Ajanta Pharma Ltd, Intas Pharmaceuticals Ltd, FDC Ltd, Alkem Laboratories Ltd, Entod Pharmaceuticals Ltd.

North America was the largest region in the eye-drop and lubricants market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the eye-drop and lubricants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the eye-drop and lubricants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the eye-drop and lubricants market by increasing costs of imported active pharmaceutical ingredients, sterile packaging materials, dispensing systems, and ophthalmic manufacturing equipment. Pharmaceutical manufacturers in North America and Europe are most affected due to reliance on imported raw materials, while Asia-Pacific faces export cost pressures. These tariffs are impacting product pricing and margin structures. However, they are also encouraging domestic API production, local packaging capabilities, and regional investment in ophthalmic manufacturing facilities.

The eye-drop and lubricants market research report is one of a series of new reports that provides eye-drop and lubricants market statistics, including eye-drop and lubricants industry global market size, regional shares, competitors with a eye-drop and lubricants market share, detailed eye-drop and lubricants market segments, market trends and opportunities, and any further data you may need to thrive in the eye-drop and lubricants industry. This eye-drop and lubricants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Eye drops and lubricants are liquid formulations applied directly to the eyes to treat various conditions or provide relief from discomfort. Eye drops may contain medications to manage issues such as infections, allergies, or glaucoma, while lubricants - commonly known as artificial tears - are primarily used to moisturize and soothe dry or irritated eyes caused by environmental factors or medical conditions.

The primary types of eye drops and lubricants are antibiotics, hormones, artificial tears, and others. Antibiotics are medications used to prevent and treat bacterial eye infections. They can be formulated as liquids, ointments, gels, or sprays and are distributed through online retail, pharmacies, supermarkets or hypermarkets, and specialty stores. These products are used for applications such as eye disease management, eye care, and related purposes, serving end users including hospitals, clinics, home care settings, and eyewear centers.

The eye-drop and lubricants market consists of sales of rewetting drops, allergy eye drops, artificial tears, redness relievers, and eye ointments and gels. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.